Pacer Advisors Inc. reduced its holdings in DocuSign, Inc. (NASDAQ:DOCU - Free Report) by 96.2% during the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 128,328 shares of the company's stock after selling 3,215,962 shares during the quarter. Pacer Advisors Inc. owned 0.06% of DocuSign worth $11,542,000 at the end of the most recent reporting period.
Other institutional investors and hedge funds have also recently modified their holdings of the company. KBC Group NV increased its position in shares of DocuSign by 209.8% in the third quarter. KBC Group NV now owns 1,156,874 shares of the company's stock worth $71,830,000 after purchasing an additional 783,419 shares during the last quarter. Caisse DE Depot ET Placement DU Quebec increased its holdings in shares of DocuSign by 42.4% in the 3rd quarter. Caisse DE Depot ET Placement DU Quebec now owns 1,459,580 shares of the company's stock worth $90,625,000 after buying an additional 434,312 shares during the last quarter. International Assets Investment Management LLC increased its holdings in shares of DocuSign by 5,660.8% in the 3rd quarter. International Assets Investment Management LLC now owns 438,914 shares of the company's stock worth $27,252,000 after buying an additional 431,295 shares during the last quarter. FMR LLC raised its position in shares of DocuSign by 16.8% during the 3rd quarter. FMR LLC now owns 2,192,885 shares of the company's stock valued at $136,156,000 after buying an additional 315,073 shares in the last quarter. Finally, Healthcare of Ontario Pension Plan Trust Fund bought a new stake in shares of DocuSign during the 2nd quarter worth $16,248,000. Hedge funds and other institutional investors own 77.64% of the company's stock.
Insider Buying and Selling at DocuSign
In other DocuSign news, Director Peter Solvik sold 10,000 shares of the company's stock in a transaction on Friday, January 10th. The shares were sold at an average price of $91.26, for a total value of $912,600.00. Following the completion of the transaction, the director now directly owns 150,253 shares in the company, valued at approximately $13,712,088.78. This represents a 6.24 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CFO Blake Jeffrey Grayson sold 15,588 shares of DocuSign stock in a transaction dated Wednesday, December 18th. The shares were sold at an average price of $97.78, for a total transaction of $1,524,194.64. Following the sale, the chief financial officer now directly owns 85,851 shares in the company, valued at $8,394,510.78. The trade was a 15.37 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 685,773 shares of company stock valued at $66,032,726 in the last 90 days. Insiders own 1.66% of the company's stock.
Analyst Ratings Changes
DOCU has been the topic of a number of research reports. UBS Group raised their price target on DocuSign from $60.00 to $100.00 and gave the company a "neutral" rating in a research report on Friday, December 6th. Royal Bank of Canada reissued a "sector perform" rating and set a $90.00 price objective (up from $57.00) on shares of DocuSign in a report on Friday, December 6th. Needham & Company LLC reaffirmed a "hold" rating on shares of DocuSign in a research note on Friday, December 6th. HSBC reiterated a "reduce" rating on shares of DocuSign in a research report on Friday, December 6th. Finally, JMP Securities reaffirmed a "market outperform" rating and issued a $124.00 price objective on shares of DocuSign in a research note on Tuesday, January 7th. Three equities research analysts have rated the stock with a sell rating, seven have issued a hold rating and three have given a buy rating to the stock. Based on data from MarketBeat.com, DocuSign has an average rating of "Hold" and an average target price of $92.45.
Check Out Our Latest Stock Analysis on DOCU
DocuSign Trading Up 0.9 %
Shares of DOCU stock traded up $0.88 during mid-day trading on Friday, reaching $96.73. The stock had a trading volume of 2,804,815 shares, compared to its average volume of 1,908,136. The firm has a market capitalization of $19.54 billion, a PE ratio of 19.94, a price-to-earnings-growth ratio of 8.63 and a beta of 0.88. The stock's 50-day moving average price is $91.32 and its two-hundred day moving average price is $72.85. DocuSign, Inc. has a 52-week low of $48.70 and a 52-week high of $107.86.
About DocuSign
(
Free Report)
DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.
Read More
Before you consider DocuSign, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and DocuSign wasn't on the list.
While DocuSign currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.